← Back to Clinical Trials
Recruiting NCT05294276

NCT05294276 Prospective Registration of Taiwan Neonatal Network (TNN)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05294276
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Neonatal Care
Study Type OBSERVATIONAL
Enrollment 26,500 participants
Start Date 2022-01-12
Primary Completion 2024-12-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 1 Year
Study Type OBSERVATIONAL
Interventions
no intervention related

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 26,500 participants in total. It began in 2022-01-12 with a primary completion date of 2024-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Taiwan Neonatal Network (TNN) is an organizational structure that unites the neonatal care centers of multiple hospitals and aims to improve the quality of medical care. Countries around the world have successively established their neonatal medical care network systems to improve the quality of their neonatal care. Since the establishment of the TNN system in 2016, after five years of retrospective statistical analysis of medical records, the establishment of the TNN network system and the short-term and mid-term goals have been completed. In order to continue and improve the long-term goals and objectives of the TNN system, to improve the indicators of newborn care in Taiwan and to establish a more complete preterm infant database, it is planned to change to prospective collection, and the future preterm infant data will be registered in the TNN system. And further establish a database of various preterm infant care outcome indicators and risk factors. After statistical correction, the various preterm infant care outcome indicators among different hospitals can be regarded as the benchmark learning objects of other hospitals, and based on empirical medicine. Medical quality improvement methods have improved the quality of medical care for premature infants in Taiwan.

Eligibility Criteria

Inclusion Criteria: Any newborn with a birth weight between 401 grams and 1500 grams or a number of weeks of birth between 22 weeks plus 0 days to 29 weeks plus 6 days of live birth, if one of the above two conditions is met, it meets the preliminary acceptance criteria. Another case meets any of the following conditions: i. Newborn born in this hospital and admitted to the hospital or ii. Newborn born in this hospital but died in the delivery room (or anywhere in this hospital) before being transferred to the intensive care unit or iii. Newborn born in the outer hospital and transferred to this hospital within 28 days of birth (the newborn has not been discharged and returned home before being transferred from the previous hospital to this hospital). Exclusion Criteria: Nil

Contact & Investigator

Central Contact

Po-Nien Tsao

✉ tsaopn@gmail.com

📞 02-23123456

Principal Investigator

Po-Nien Tsao

PRINCIPAL INVESTIGATOR

National Taiwan University Hospital

Frequently Asked Questions

Who can join the NCT05294276 clinical trial?

This trial is open to participants of all sexes, up to 1 Year, studying Neonatal Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05294276 currently recruiting?

Yes, NCT05294276 is actively recruiting participants. Contact the research team at tsaopn@gmail.com for enrollment information.

Where is the NCT05294276 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT05294276 clinical trial?

NCT05294276 is sponsored by National Taiwan University Hospital. The principal investigator is Po-Nien Tsao at National Taiwan University Hospital. The trial plans to enroll 26,500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology